4Ross R. Atherosclerosis: an inflammatory disease [ J ]. N Engl J Med, 1999, 340:115-126.
5Harry Yu, Nader Rifai. High - sensitivity C- reactive protein and athersclerosis; from theory to therapy[ J ]. Clinical Biochemistty, 2000, 33(8) :601-610.
6Morley J J, Kushner I. Serum. C - reactive protein levels in disease[ J]. Ann N Y Aead Sci, 1982,389:406-418.
7Macy EM Hayes TE, Tracy RP. Variability in the measurement of C- reactive protein in healthy subjects:implications for reference intervals and epidemiological appilication[J]. Clinical Chemistry 1997,43:52-58.
8Rifal N, Ridker PM. Proposed cardiovascular risk assessment algorithm using high- sensitivity C- reactive protein and lipid screening[ J ]. Clin Chem, 2001,47:28-30.
9Ledue TB, Rifa N. Itigh se.silivilv immunoassays for C- reactive prorein: promises and pitfalls JI[ J ]. Clin Chem Lab Med,2001.39( 11 ) : 1171-1176.
10Rothkrantz - Kos S, Schmitz MP, Bekers O, et al, High - sensitivity C- reactive protein methods examined JI[J ]. Clin Chem,2002, 48(2 ):359-362.
6Xasojia K, Schwab C, McGeer EG. Generation of C-reactive protein and compleent components in a then)sclerotic plaques[J]. Am J Pathol,2001, 158(3) : 1039.
7[1]Ridker PM,Buring JE,Shih J,et al.Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women[J].Circulation,1998,98(6):731-732.
8Cushman M, Folsom AR, Wang L, et al. Fibrin fragment D-dimer and the risk of future venous thrombosis [ J ]. Blood,2003,101 (4) : 1243 - 1248.
9Barber M, Langhome P, Rumley A, et al. Hemostatic function and progressing ischemic stroke:D-dimer predicts early clinical progres- sion[ J]. Stroke ,2004,35 (6) : 1421 - 1425.
10Muir KW, Weft C J, Alwan W, et al. C-reactive protein and out-come after ischemie stroke[J]. Stroke, 1999,30 ( 5 ) :981 - 985.
